<DOC>
	<DOC>NCT00520260</DOC>
	<brief_summary>To compare bromfenac 0.09% and ketorolac 0.4% when used concomitantly with cyclosporine ophthalmic emulsion 0.05% in improving patient comfort during the induction phase of treatment for chronic dry eye disease</brief_summary>
	<brief_title>Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Must be in general good health Diagnosis of moderate to severe dry eye syndrome Patients who are unlikely to respond to cyclosporine ophthalmic emulsion therapy Patients who are pregnant or nursing females Unwilling to discontinue use of contact lenses during the runin and duration of the study Presence or history of any systemic or ocular disorder or condition that could possibly interfere with the interpretation of the study results in the study eye Previous treatment failure on CSA 0.05% (Restasis) Known hypersensitivity to any component of the study or procedural medications Participation in any other clinical trial within 30 days prior to screening Known contraindication to any study medication or any of their components. Should not be taking any oral antihistamines, beta blockers or diuretics.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>